"Cefoxitin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A semisynthetic cephamycin antibiotic resistant to beta-lactamase.
Descriptor ID |
D002440
|
MeSH Number(s) |
D02.065.589.099.249.250.222 D02.886.665.074.250.222 D03.633.100.300.249.250.222
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cefoxitin".
Below are MeSH descriptors whose meaning is more specific than "Cefoxitin".
This graph shows the total number of publications written about "Cefoxitin" by people in this website by year, and whether "Cefoxitin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 1 | 0 | 1 |
2010 | 2 | 0 | 2 |
2011 | 1 | 0 | 1 |
2017 | 0 | 1 | 1 |
2018 | 2 | 3 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Cefoxitin" by people in Profiles.
-
Mycobacterium abscessus Infection During Ustekinumab Treatment in Crohn's Disease: A Case Report and Review of the Literature. J Crohns Colitis. 2018 Nov 28; 12(12):1505-1507.
-
Ceftaroline Resistance by Clone-Specific Polymorphism in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2018 09; 62(9).
-
Higher versus Lower Dose of Cefotetan or Cefoxitin for Surgical Prophylaxis in Patients Weighing One Hundred Twenty Kilograms or More. Surg Infect (Larchmt). 2018 Jul; 19(5):504-509.
-
Comparison of intravenous versus combined oral and intravenous antimicrobial prophylaxis (COMBINE) for the prevention of surgical site infection in elective colorectal surgery: study protocol for a multicentre, double-blind, randomised controlled clinical trial. BMJ Open. 2018 04 12; 8(4):e020254.
-
Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus. Ann Clin Microbiol Antimicrob. 2018 Feb 20; 17(1):5.
-
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections. J Antimicrob Chemother. 2017 05 01; 72(5):1364-1372.
-
[Mycobacterium abscessus pulmonary infection treated with tigecyclin-amikacin and cefoxitin in a diabetic patient]. Med Mal Infect. 2011 Aug; 41(8):446-8.
-
[Evaluation of the performance of the MicroScan Pos Breakpoint Combo Panel Type 28 for susceptibility testing of Staphylococcus aureus: low-range minimum inhibitory concentration of vancomycin, cefoxitin screening, and inducible clindamycin resistance detection]. Korean J Lab Med. 2010 Dec; 30(6):637-46.
-
A severe case of cefoxitin-induced immune hemolytic anemia. Acta Haematol. 2010; 124(4):197-9.
-
Comparison of cefoxitin and moxalactam 30 microg disc diffusion methods for detection of methicillin resistance in coagulase-negative staphylococci. J Antimicrob Chemother. 2007 Apr; 59(4):763-6.